Robert Ghenchev Overview

  • Primary Position
  • Managing Partner...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 2

  • Med. Deal Size

  • Med. Valuation

Robert Ghenchev General Information

Biography

Mr. Robert Ghenchev serves as Managing Partner and Head of Growth Investments & Member of the Life Sciences Operating Committee at Novo Holdings. He serves as Vice President at Moelis & Company. He joined Novo Holdings in January 2018 as a director of the Principal Investments team, responsible for growth equity investments. Before joining Novo Holdings, he was a Senior Vice President at Moelis & Company in London where he focused on mergers and acquisitions within the Healthcare Industry. Before Moelis, he was part of the UK Mergers & Acquisitions team at Deutsche Bank in London. He holds a J.Hons. B.A. degree in Finance and Economics from McGill University and an M.Sc. degree in Financial Economics from the University of Oxford. He also serves as a Board Member at Tempus, Quanta Dialysis Technologies, and Exscientia. He served as a Board Member at Mission Bio.

Contact Information

Primary Position
Managing Partner and Head of Growth Investments & Member of the Life Sciences Operating Committee, Novo Holdings
Education
University of Oxford, MS (Master of Science)
McGill University, BA (Bachelor of Arts)
Gender
Male
Phone
+1 (415)
Address
  • One Market Street, Steuart Tower
  • 17th Floor
  • San Francisco, CA 94105
  • United States
+1 (415)

Robert Ghenchev Positions (1)

Firm name Firm type Title Location Industry Since
Novo Holdings Investor Managing Partner and Head of Growth Investments & Member of the Life Sciences Operating Committee Copenhagen, Denmark Corporate Venture Capital

Robert Ghenchev Board Seats (2)

Company Industry Ownership Status Financing Status Location Since
Oxford BioMedica Biotechnology Publicly Held Corporation Oxford, United Kingdom
Quanta Dialysis Technologies Other Devices and Supplies Privately Held (backing) Venture Capital-Backed Warwick, United Kingdom

Robert Ghenchev Lead Partner on Deals (11)

Robert Ghenchev has been the lead partner on 11 deals. Their latest deal was with Quanta Dialysis Technologies, a other devices and supplies company. The deal was made for on 18-Nov-2024.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Quanta Dialysis Technologies 18-Nov-2024 Later Stage VC (Series E) Completed Other Devices and Supplies Warwick, United Kingdom
Mission Bio 06-May-2022 Completed Discovery Tools (Healthcare) San Francisco, CA
Quanta Dialysis Technologies 23-Jun-2021 Completed Other Devices and Supplies Warwick, United Kingdom
Exscientia 27-Apr-2021 Completed Drug Discovery Oxford, United Kingdom
Tempus AI 10-Dec-2020 Completed Biotechnology Chicago, IL
Mission Bio 13-Aug-2020 Completed Discovery Tools (Healthcare) San Francisco, CA
Oxford BioMedica 23-Jun-2020 Completed Biotechnology Oxford, United Kingdom
Tempus AI 13-Mar-2020 Completed Biotechnology Chicago, IL
Tempus AI 30-May-2019 Later Stage VC (Series F) Completed Biotechnology Chicago, IL
Oxford BioMedica 28-May-2019 PIPE Completed Biotechnology Oxford, United Kingdom

Robert Ghenchev Network (220)

Board Members (71)

Name Company Representing Location From
William Hyun Ph.D Mission Bio Genoa Ventures San Francisco, CA
Lloyd Mandell Quanta Dialysis Technologies Glenview Capital Management Warwick, United Kingdom
Quanta Dialysis Technologies Self Warwick, United Kingdom
Quanta Dialysis Technologies Self Warwick, United Kingdom
Mission Bio Mayfield Fund San Francisco, CA

Portfolio Executives (118)

Name Company Role Deal date Location
Alejandro Galindo Quanta Dialysis Technologies Chief Executive Officer 18-Nov-2024 Warwick, United Kingdom
Willem Baralt Quanta Dialysis Technologies Chief Financial Officer 18-Nov-2024 Warwick, United Kingdom
Quanta Dialysis Technologies Chief Engineer 18-Nov-2024 Warwick, United Kingdom
Quanta Dialysis Technologies Chief Medical Officer 18-Nov-2024 Warwick, United Kingdom
Quanta Dialysis Technologies Co-Founder, Chief Executive Officer & Board Member 18-Nov-2024 Warwick, United Kingdom

Fund Team Members (31)

Name Investor Fund Fund Location
Aleks Engel Ph.D Novo Holdings Repair Impact Fund Copenhagen, Denmark
Aleks Engel Ph.D REPAIR Impact Fund Repair Impact Fund Hellerup, Denmark
Novo Holdings Copenhagen, Denmark
REPAIR Impact Fund Hellerup, Denmark
Novo Holdings Copenhagen, Denmark

Robert Ghenchev Affiliated Funds (2)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
Repair Impact Fund Novo Holdings Venture Capital - Early Stage Closed 2018
Renewable Energy Partnership I Novo Holdings Infrastructure Debt Closed 2021

Robert Ghenchev FAQs

  • Who is Robert Ghenchev?

    Mr. Robert Ghenchev serves as Managing Partner and Head of Growth Investments & Member of the Life Sciences Operating Committee at Novo Holdings.

  • How much does Robert Ghenchev typically invest?

    Robert Ghenchev's median deal size is .

  • What is Robert Ghenchev’s main position?

    Robert Ghenchev’s primary position is Managing Partner and Head of Growth Investments & Member of the Life Sciences Operating Committee.

  • How many active board seats does Robert Ghenchev hold?

    Robert Ghenchev holds 2 board seats including Oxford BioMedica and Quanta Dialysis Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »